Jackson Alldredge

Full contact info


Travere Therapeutics – $316 Million Convertible Note Offering

March 9, 2022

Cooley advised Travere Therapeutics on its $316 million offering of 2.25% convertible senior notes due 2029. Travere Therapeutics is a biopharmaceutical company developing and commercializing therapies for people living with rare diseases. Partners Jason Kent, Mischi a Marca and Jason Savich led the Cooley team.

Related contacts

Jason Kent
Partner, New York
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Asa Henin
Special Counsel, San Diego
Jessica Wade
Paralegal Specialist, San Diego
Timothy Nguyen
Special Counsel, San Francisco
Jackson Alldredge
Associate, Colorado

Related Practices & Industries